FrancophonIA/ELRC3.0 huggingface dataset:
English: Czech Republic SANDOZ s.r.o.
Estonian: SANDOZ s.r.o.
English: Sanval 10 mg filmsko obožene tablete 10 mg
Estonian: Sanval 10 mg filmsko obožene tablete
English: Zolpidem "Hexal" - Filmtabletten
Estonian: Zolpidem "Hexal" - Filmtabletten 10 mg
English: Italfarmaco S.p.A. Viale Fulvio 330 20126 Milano Italy
Estonian: Viale Fulvio 330 20126 Milano Italy
English: Zolpeduar sublingual tablet oral use
Estonian: Zolpeduar keelealune tablett keelealune
English: ITALFARMACO S.p.A. Viale Fulvio Testi 330, 20126 Milano, Italy
Estonian: Viale Fulvio Testi 330, 20126 Milano, Italy
English: Zolpidem Genthion coated tablet oral use
Estonian: Zolpidem Genthion kaetud tablett
English: Zolpidemtartaat Actavis 5 mg, tabletten tablet oral use
Estonian: Zolpidemtartaat Actavis 5 mg, tabletten tablett
English: Edluar 5 mg, tablet voor sublinguaal gebruik sublingual tablet sublingual use
Estonian: Edluar 5 mg, tablet voor sublinguaal gebruik keelealune tablett keelealune
English: Edluar 10 mg, tablet voor sublinguaal gebruik sublingual tablet sublingual use
Estonian: Edluar 10 mg, tablet voor sublinguaal gebruik keelealune tablett keelealune
English: Edluar 10 mg Sublingualtabletten 10 mg sublingual tablet sublingual use
Estonian: Edluar 10 mg Sublingualtabletten 10 mg keelealune tablett keelealune
English: Sanval 10 mg filmom obložene tablete 10 mg
Estonian: Sanval 10 mg filmom obložene tablete
English: Zolsana 5 mg coated tablets coated tablet oral use
Estonian: Zolsana 5 mg coated tablets kaetud tablett
English: Lunata 10 mg filmom obložene tablete 10 mg
Estonian: Lunata 10 mg filmom obložene tablete
English: Dodorest coated tablet oral use
Estonian: Dodorest kaetud tablett
English: Stilnoct 10mg Film-coated Tablets
Estonian: Stilnoct 10mg film-coated tablets kaetud tablett
English: Zolpidem-CT 5 mg Filmtabletten
Estonian: Zolpidem-CT 5 mg Filmtabletten 5 mg
English: Zolpidemtartraat ADOH 10 mg, bruistabletten effervescent tablet oral use
Estonian: Zolpidemtartraat ADOH 10 mg, bruistabletten kihisev tablett
English: Zolpidem-Actavis 10 mg Filmtabletten 10 mg
Estonian: Zolpidem-Actavis 10 mg Filmtabletten
English: Zolpidem Sandoz 10 mg Filmtabletten 10 mg
Estonian: Zolpidem Sandoz 10 mg Filmtabletten
English: Zoldem 10 mg film coated tablets
Estonian: Zoldem 10 mg film coated tablets 10 mg
English: Zolpidemtartraat Actavis 10 mg, tabletten tablet oral use
Estonian: Zolpidemtartraat Actavis 10 mg, tabletten tablett
English: EDLUAR 10 mg nyelvalatti tabletta 10 mg sublingual tablet sublingual use
Estonian: EDLUAR 10 mg nyelvalatti tabletta 10 mg keelealune tablett keelealune
English: Edluar 10 mg sublingual tablets sublingual tablet oral use
Estonian: Edluar 10 mg sublingual tablets keelealune tablett keelealune
English: Zolpitop coated tablet oral use
Estonian: Zolpitop kaetud tablett
English: Edluar 5 mg sublingual tablets sublingual tablet oral use
Estonian: Edluar 5 mg sublingual tablets keelealune tablett keelealune
English: Zolpidemtartraat ratiopharm 5 mg, tabletten tablet oral use
Estonian: Zolpidemtartraat ratiopharm 5 mg, tabletten tablett
English: Sweden ratiopharm GmbH Graf Arco Strasse 3 D-89079 Ulm Germany
Estonian: Rootsi ratiopharm GmbH Graf Arco Strasse 3 D-89079 Ulm Germany
English: United Kingdom ratiopharm GmbH Graf Arco Strasse 3 D-89079 Ulm Germany
Estonian: Ühendkuningriik ratiopharm GmbH Graf Arco Strasse 3 D-89079 Ulm Germany
English: Zolpidemtartraat ratiopharm 10 mg, tabletten tablet oral use
Estonian: Zolpidemtartraat ratiopharm 10 mg, tabletten tablett
English: Zolsana 10 mg coated tablets coated tablet oral use
Estonian: Zolsana 10 mg coated tablets kaetud tablett
English: Germany ratiopharm GmbH Graf Arco Strasse 3 D-89079 Ulm Germany
Estonian: Saksamaa ratiopharm GmbH Graf Arco Strasse 3 D-89079 Ulm Germany
English: Edluar 10 mg Sublingualtabletten 10 mg sublingual tablet oral use
Estonian: Edluar 10 mg Sublingualtabletten 10 mg keelealune tablett suukaudne
English: Zolsana 5 mg filmsko obložene tablete 5 mg
Estonian: Zolsana 5 mg filmsko obložene tablete
English: Zolsana 5 mg filmom obložene tablete 5 mg
Estonian: Zolsana 5 mg filmom obložene tablete
English: tablet oral use
Estonian: keelealune tablett keelealune
English: Edluar 5 mg podjezične tablete sublingual tablet sublingual use
Estonian: Edluar 5 mg podjezične tablete keelealune tablett keelealune
English: Edluar 10 mg podjezične tablete sublingual tablet sublingual use
Estonian: Edluar 10 mg podjezične tablete keelealune tablett keelealune
English: Edluar 5 mg Sublingualtabletten sublingual tablet sublingual use
Estonian: Edluar 5 mg Sublingualtabletten 5 mg keelealune tablett keelealune
English: Edluar 5mg sublingual tablets sublingual tablet oral use
Estonian: Edluar 5mg sublingual tablets keelealune tablett suukaudne
English: Edluar 10mg sublingual tablets sublingual tablet oral use
Estonian: Edluar 10mg sublingual tablets keelealune tablett suukaudne
English: coated tablet oral use
Estonian: Edluar keelealune tablett keelealune
English: The European Commission issued a decision on 5 October 2010.
Estonian: Euroopa Komisjon tegi otsuse 5. oktoobril 2010.
English: The company wanted the authorisation to be recognised in Bulgaria, Germany, France, Ireland and Italy (the ‘concerned Member States').
Estonian: Ettevõte soovis, et müügiluba tunnustataks Bulgaarias, Saksamaal, Prantsusmaal, Iirimaal ja Itaalias (asjaomased liikmesriigid).
English: Outcome of a procedure under Article 29 of Directive 2001/83/EC as amended
Estonian: Direktiivi 2001/83/EÜ artikli 29 kohase esildismenetluse tulemused
English: Kristina Dunder (Sweden)
Estonian: Kristina Dunder (Rootsi)
English: Daniela Melchiorri (Italy)
Estonian: Daniela Melchiorri (Itaalia)
English: What is Norsed Combi D?
Estonian: Mis on Norsed Combi D?
English: However, the Member States were not able to reach an agreement and the Swedish medicines regulatory agency referred the matter to the CHMP for arbitration on 29 April 2010.
Estonian: Liikmesriigid ei jõudnud aga kokkuleppele ning 29. aprillil 2010 tegi Rootsi ravimiamet inimravimite komiteele selles küsimuses esildise vahekohtumenetluse algatamiseks.
English: 20 May 2010
Estonian: 20. mai 2010
English: Why was Norsed Combi D reviewed?
Estonian: Miks Norsed Combi D taotlus uuesti üle vaadati?
English: 5 October 2010
Estonian: 5. oktoober 2010
English: Based on evaluation of the currently available data and the scientific discussion within the Committee, the CHMP concluded that the benefits of Norsed Combi D outweigh its risks, and therefore the marketing authorisation for Norsed Combi D should be granted in all concerned Member States.
Estonian: Praeguseks kättesaadavate andmete hindamise ja komitees toimunud teadusliku arutelu põhjal jõudis inimravimite komitee järeldusele, et Norsed Combi D kasulikkus on suurem kui sellega kaasnevad riskid, ning soovitas anda kõigis asjaomastes liikmesriikides Norsed Combi D müügiloa.
English: The grounds for the referral were concerns over the evidence provided of the efficacy of this combination medicine, the validity of claims that this way of combining active substances would bring a benefit to patients compared with the individual active substances, and the validity of claims that the medicine improved compliance (the ability of patients to stick to their treatment).
Estonian: Esildis tehti, kuna esines kahtlusi kõnealuse ravikomplekti efektiivsuse näitamiseks esitatud andmete suhtes, samuti väidete suhtes, et asjaomase toimeainete kombinatsiooni kasulikkus patsientidele on suurem kui toimeainetel eraldi ning et kõnealune ravikomplekt parandab raviskeemist kinnipidamist.
English: Sanofi-aventis S.p.A. submitted Norsed Combi D for mutual recognition on the basis of the initial authorisation granted by Sweden on 3 October 2006.
Estonian: esitas Norsed Combi D vastastikuse tunnustamise taotluse, võttes aluseks Rootsis 3. oktoobril 2006 antud algse müügiloa.
English: Co-rapporteur:
Estonian: Kaashindaja:
English: The active substance in the tablets, risedronate sodium, is a bisphosphonate.
Estonian: Tablettide toimeaine naatriumrisedronaat on bisfosfonaat.
English: Norsed Combi D is used for the treatment of osteoporosis (a disease that makes bones fragile) in women who have been through the menopause.
Estonian: Norsed Combi D-d kasutatakse osteoporoosi (luu-urbnemuse) raviks menopausijärgses eas naistel.
English: It is used to reduce the risk of fractures (in the hip and spine.
Estonian: Seda kasutatakse puusaluu- ja lülisambamurdude ohu vähendamiseks.
English: Norsed Combi D is a medicine that contains three active substances, risedronate sodium, calcium carbonate and colecalciferol.
Estonian: Norsed Combi D sisaldab toimeainetena naatriumrisedronaati, kaltsiumkarbonaati ja kolekaltsiferooli.
English: The active substances in the effervescent granules provide calcium and vitamin D, which are needed for normal bone formation.
Estonian: Kihisevate graanulite toimeained varustavad organismi luukoe moodustumiseks vajaliku kaltsiumi ja Dvitamiiniga.
English: Questions and answers on Norsed Combi D and associated names (risedronate sodium 35 mg tablets / calcium plus colecalciferol 1000 mg/880 IU effervescent granules) EMA/CHMP/405858/2010 rev.
Estonian: Teave Norsed Combi D ja sarnaste nimetuste kohta (naatriumrisedronaat, 35 mg tabletid / kaltsium, 1000 mg + kolekaltsiferool, 880 RÜ, kihisevad graanulid) EMA/CHMP/405858/2010 rev.
English: It consists of tablets containing 35 mg risedronate sodium, together with sachets of effervescent granules containing 1000 mg calcium as calcium carbonate and 880 IU colecalciferol.
Estonian: Norsed Combi D ravikomplekti kuuluvad 35 mg naatriumrisedronaati sisaldavad tabletid ning kihisevate graanulite pakikesed, mis sisaldavad 1000 mg kaltsiumkarbonaati ja 880 RÜ kolekaltsiferooli.
English: Questions and answers on Norsed Combi D and associated names (risedronate sodium 35 mg tablets / calcium plus colecalciferol 1000 mg/880 IU effervescent granules)
Estonian: Teave Norsed Combi D ja sarnaste nimetuste kohta (naatriumrisedronaat, 35 mg tabletid / kaltsium, 1000 mg + kolekaltsiferool, 880 RÜ, kihisevad graanulid)
English: The European Medicines Agency has completed an arbitration procedure following a disagreement among Member States of the European Union (EU) regarding the authorisation of the medicine Norsed Combi D. The Agency's Committee for Medicinal Products for Human Use (CHMP) has concluded that the benefits of Norsed Combi D outweigh its risks, and that the marketing authorisation granted in Sweden can be recognised in other Member States of the EU.
Estonian: Ravimiameti inimravimite komitee otsustas, et Norsed Combi D kasulikkus on suurem kui sellega kaasnevad riskid ning et ravimile võib anda müügiloa lisaks Rootsile ka teistes ELi liikmesriikides.
English: MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Pack size
Estonian: Tugevus Ravimvorm
English: Efficacy studies under field conditions have not been conducted.
Estonian: Efektiivsuse uuringuid kohapealsetes tingimustes ei ole läbi viidud
English: Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (http://www.ema.europa.eu).
Estonian: Üksikasjalikku teavet antud veterinaarravimi kohta leiab Euroopa Ravimiameti koduleheküljelt http://www.ema.europa.eu
English: Keep the bag tightly closed.
Estonian: Hoida kott tihedalt suletuna.
English: Where feed intake is reduced, use the following formula:
Estonian: Kui söödakogus on vähenenud, kasutage järgmist valemit:
English: Opened bags should not be stored.
Estonian: Avatud kotte ei tohi säilitada.
English: OTHER CONDITIONS:
Estonian: • MUUD TINGIMUSED:
English: Tylvalosin has a sixteen membered ring.
Estonian: Tülvalosiinil on kuueteistkümne lüliga ring.
English: If you notice any side effects, even those not already listed in this package leaflet or you think that the medicine has not worked, please inform your veterinary surgeon.
Estonian: Kui täheldate mistahes kõrvaltoimeid, k.a selliseid mida pole käesolevas pakendi infolehes loetletud või kui te arvate et ravim pole toimet avaldanud, siis teavitage palun sellest oma veterinaararsti.
English: Their effect is essentially confined to rapidly dividing organisms.
Estonian: Nende toime piirdub põhiliselt kiiresti jagunevate organismidega.
English: ATCvet code: QJ01FA92.
Estonian: ATCvet kood: QJ01FA92.
English: Therapeutic classification
Estonian: Therapeutiline klassifikatsioon
English: The tmax for tylvalosin is about 2.2 hours; the terminal half-life for the elimination is approximately 2.2 hours.
Estonian: Tülvalosiini tmax on ligikaudu 2,2 tundi; lõplik eliminatsiooni poolväärtusaeg on ligikaudu 2,2 tundi.
English: 10 days
Estonian: 10 päeva
English: Laboratory studies in animals have not produced any evidence of a teratogenic effect.
Estonian: Laboratoorsed uuringud loomadel ei ole näidanud teratogeenset toimet.
English: Major incompatibilities:
Estonian: Suured sobimatused:
English: The clinical relevance of this reduced susceptibility is not fully explored.
Estonian: Tundlikkuse vähenemise kliiniline tähtsus ei ole veel täielikult selge.
English: In order to obtain the correct dose, the concentration of Aivlosin has to be adjusted accordingly.
Estonian: Õige annuse saamiseks tuleb vastavalt kohandada Aivlosini kontsentratsiooni.
English: Pharmacotherapeutic group: antibacterials for systemic use, macrolides.
Estonian: Farmakoterapeutiline rühm: antibakteriaalsed ravimid süsteemseks kasutamiseks, makroliidid.
English: One additional yearly periodic safety update report (PSUR) is required, and thereafter PSURs shall be submitted at three-yearly intervals, unless otherwise required.
Estonian: Tuleb esitada üks täiendav iga-aastane perioodiline ohutusaruanne ja seejärel esitatakse perioodilised ohutusaruanded iga kolme aasta järel, kui ei ole nõutud teisiti.
English: Keep the container tightly closed.
Estonian: Hoida mahuti tihedalt suletuna.
English: Specific pharmacovigilance requirements:
Estonian: Konkreetsed ravimiohutuse järelevalve nõuded:
English: The veterinary medicinal product should only be added to dry non-pelleted feed.
Estonian: Veterinaarravimit tohib lisada ainult kuiva, mittegranuleeritud sööda hulka.
English: Overdose (symptoms, emergency procedures, antidotes):
Estonian: Üleannustamine (sümptomid, esmaabi, antidoodid):
English: Eggs: zero days
Estonian: Munad: null päeva
English: Magazynowa 5, 66-446 Deszczno
Estonian: 66-446 Deszczno
English: (attached as concertina label directly to the immediate package or as a back label for the 400 g sachet for one language)
Estonian: (kinnitatakse lahtikäiva etiketina otse vahetule pakendile või 400 g kotikese tagumisele küljele, kui on ükskeelne)
English: PPE (ileitis) and swine dysentery
Estonian: PPE (ileiit) ja sigade düsenteeria
English: Eggs (chicken): zero days.
Estonian: Munad (kana): null päeva.
English: Feed to which the oral powder has been added should be replaced if not consumed within 24 hours.
Estonian: Sööt, millesse on lisatud suukaudset pulbrit, tuleb välja vahetada, kui seda pole 24 tunni jooksul ära tarvitatud.
English: Kg Premix/tonne feed =
Estonian: Kg ravimsööda eelsegu/tonni sööda kohta =
English: 1 kg/tonne*
Estonian: 1 kg/tonn*
English: Date of last renewal: 9 September 2014
Estonian: Esmase müügiloa väljastamise kuupäev: 9. september 2004 Müügiloa viimase uuendamise kuupäev: 9. september 2014
English: White granules.
Estonian: Valged graanulid.
English: Bacteria can develop resistance to antimicrobial substances.
Estonian: Bakteritel võib kujuneda resistentsus antibakteriaalsete ainete suhtes.
English: 2 kg/tonne*
Estonian: 2 kg/tonn*
English: Chickens and turkeys.
Estonian: Kanatibud ja kalkunid
English: They bind to the donor site and prevent the translocation necessary for keeping the peptide chain growing.
Estonian: Nad seostuvad doonorsaidiga ja takistavad translokatsiooni, mis on vajalik peptiidahela kasvu jätkumiseks.
English: Pregnancy and lactation:
Estonian: Tiinus ja laktatsioon:
English: Consideration must be given to pigs whose daily feed intake is reduced or restricted.
Estonian: Tuleb võtta arvesse seda, kas sea päevast toidukogust on piiratud või vähendatud.
English: The strategy for Mycoplasma gallisepticum infection should include efforts to eliminate the pathogen from the parent generation.
Estonian: Mycoplasma gallisepticum infektsiooni suhtes rakendatav strateegia peab hõlmama meetmeid vanemalt põlvkonnalt saadava patogeeni elimineerimiseks.
English: Do not use within 14 days of the start of the laying period.
Estonian: Mitte kasutada 14 päeva jooksul enne munemisperioodi algust.
English: 60-66, planta 13
Estonian: Avenida Río de Janeiro, 60-66, planta 13
English: This is achieved by thoroughly mixing Aivlosin into approximately 200-500 g of feed and then thoroughly mixing this pre-mixture into the remainder of the daily ration.
Estonian: Selleks lisatakse Aivlosin hoolikalt segades ligikaudu 200-500 g söödasse ning segatakse see eelsegu põhjalikult ülejäänud päevase söödakoguse sisse.
English: This is followed by a second treatment with 25 mg tylvalosin per kg bodyweight per day in drinking water for 3 consecutive days at the period of risk, i.e. at times of management stress such as administration of vaccines (typically when birds are 2-3 weeks old).
Estonian: Edasi teise ravikuurina 25 mg tülvalosiini kg kehamassi kohta päevas, mida manustatakse joogiveega 3 järjestikusel päeval riskiperioodil, s.t stressi vähendamiseks, näiteks vaktsiinide manustamise ajal (tavaliselt 2-3 nädala vanuses).
English: The intake of medicated water depends on the clinical condition of the animals.
Estonian: Ravimit sisaldava joogivee tarbimine sõltub linnu kliinilisest seisundist.
English: They are generally considered bacteriostatic.
Estonian: Neid peetakse üldjuhul bakteriostaatilisteks.
English: The feed containing the oral powder should be provided as the sole ration for the periods recommended above.
Estonian: Suukaudset pulbrit sisaldavat sööta tuleks anda eespool soovitatud perioodide jooksul ainsa söödana.
English: The terminal half-lives for the elimination of tylvalosin and its active metabolite 3-AT range from 1 to 1.45 hours.
Estonian: Tülvalosiini ja selle aktiivse metaboliidi 3-AT eliminatsiooni lõplikud poolväärtusajad on 1 kuni 1,45 tundi.
English: Manufacturer responsible for batch release: Cod Beck Blenders Limited Cod Beck Estate
Estonian: Partii vabastamise eest vastutav tootja: Cod Beck Blenders Limited Cod Beck Estate
English: Skin and fat Liver Tylvalosin Poultry 200 µg/kg Eggs The excipients listed in section 6.1 of the SPC either are allowed substances for which Table 1 of the annex to Commission Regulation (EU) No 37/2010 indicates that no MRLs are required, or are considered as not falling within the scope of Regulation (EC) No 470/2009 when used as in this product.
Estonian: Abiained, mis on loetletud ravimi omaduste kokkuvõtte lõigus 6.1, on kas lubatud ained, millele Komisjoni määruse (EL) nr 37/2010 lisa tabelis 1 viidatakse kui ravimjääkide piirnorme mittenõudvatele, või neid loetakse Määruse (EÜ) nr 470/2009 reguleerimisalasse mittekuuluvateks, kui neid kasutatakse nii nagu selles veterinaarravimis.
English: Tylvalosin has been shown to cause hypersensitivity (allergic) reactions in laboratory animals; therefore, people with known hypersensitivity to tylvalosin should avoid contact with this product.
Estonian: Tülvalosiin on põhjustanud katseloomadel ülitundlikkusreaktsioone (allergia), seetõttu inimesed, kes on tülvalosiini suhtes ülitundlikud, peaksid kokkupuudet selle ravimiga vältima.
English: Do not use within 21 days of the start of the laying period.
Estonian: Mitte kasutada 21 päeva jooksul enne munemisperioodi algust.
English: If this is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target bacteria.
Estonian: Kui seda ei ole võimalik teha, tuleb ravi aluseks võtta kohalikud (piirkonna, talu tasandi) epidemioloogilised andmed sihtbakterite tundlikkuse kohta.
English: The pig to be treated should be weighed and the amount of feed that the pig is likely to consume should be estimated, based on a daily feed intake equivalent to 5% of bodyweight.
Estonian: Ravitavad sead tuleb üle kaaluda, et arvutada välja nende poolt tarbitava sööda hinnanguline kogus, eeldades, et päevane söödakogus vastab 5%-le kehamassist.
English: Wash contaminated skin.
Estonian: Saastunud nahk tuleb puhtaks pesta.
English: The MIC of tylvalosin for Ornithobacterium rhinotracheale ranges from 0.016 to 32 μg/ml.
Estonian: Tülvalosiini MIC Ornithobacterium rhinotracheale'i suhtes on vahemikus 0,016-32 μg/ml.
English: Pelleting conditions involve a single pre-conditioning step with steam for 5 minutes and pelleting at not more than 70 °C under normal conditions.
Estonian: Granuleerimine hõlmab normaalsetel tingimustel ühekordset eeltöötlemist auruga 5 minuti jooksul ja seejärel granuleerimist kuni 70 °C juures.
English: Swine enzootic pneumonia
Estonian: Sigade ensootiline pneumoonia
English: Efficacy of tylvalosin against O. rhinotracheale in turkeys was demonstrated in a challenge model using co-infection with avian metapneumovirus and a single strain of O. rhinotracheale under strictly controlled conditions.
Estonian: Tülvalosiini O. rhinotracheale vastane efektiivsus kalkunitel ilmnes nakatumise esilekutsumise uuringus, milles kasutati kaasnevat nakatamist lindude metapneumoviirusega ja O. rhinotracheale ühe tüvega rangelt kontrollitud tingimustes.
English: The active metabolite 3-AT has a mean concentration of 57.9 ng/g and 441 ng/g, respectively.
Estonian: Aktiivse metaboliidi 3-AT keskmine kontsentratsioon on vastavalt 57,9 ng/g ja 441 ng/g.
English: Medicated drinking water should be replaced every 24 hours.
Estonian: Ravimiga joogivett tuleb asendada iga 24 tunni järel.
English: DG Nucleus ΕΠΕ N.Χαρίτου 11
Estonian: N.Χαρίτου 11
English: For the full list of excipients, see section 6.1.
Estonian: Abiainete täielik loetelu on esitatud punktis 6.1.
English: Do not release pheasants for at least two days after the end of medication.
Estonian: Lihale ja söödavatele kudedele: 2 päeva Ärge vabastage faasaneid vähemalt kahe päeva jooksul pärast ravi lõppu.
English: The oral powder is for use in individual pigs on farms where only a small number of pigs are to receive the treatment.
Estonian: Suukaudne pulber on mõeldud ainult sigade individuaalseks raviks põllumajandusettevõttes, kus ravitavate sigade arv on väike.
English: The veterinary medicinal product may be mixed directly into the drinking water system or first mixed as a stock solution into a smaller amount of water, which is then added into the drinking water system.
Estonian: Veterinaarravimi võib segada otse joogiveesüsteemi või segada algul kontsentreeritud lahusena väiksema joogiveekogusega, mida seejärel lisatakse joogiveesüsteemi.
English: Medication should only be used for short-term amelioration of clinical signs in breeder flocks whilst awaiting confirmation of diagnosis of Mycoplasma gallisepticum infection.
Estonian: Ravimit tohib aretuskarjades kasutada ainult lühiajaliselt kliiniliste nähtude leevendamiseks sel ajal, kui oodatakse Mycoplasma gallisepticum infektsiooni kinnitust.
English: Dose rate (mg/kg bodyweight) x bodyweight (kg) Daily feed intake (kg) x Premix strength (mg/g)
Estonian: Sisaldus söödas (mg/kg kehamassi kohta) x kehamass (kg) Päevane söödakogus (kg) x toimeainekogus ravimsööda eelsegu (mg/g)
English: Larger groups should be treated with medicated feeding stuff containing the premix.
Estonian: Suuremaid loomarühmi tuleb ravida eelsegu sisaldava ravimsöödaga.
English: Bodyweight range (kg)
Estonian: Kehamassi vahemik (kg)
English: For use in individual pigs on farms where only a small number of pigs are to receive the treatment.
Estonian: Sigade individuaalseks raviks põllumajandusettevõttes, kus ravitavate sigade arv on väike.
English: Medicated feed may then be pelleted.
Estonian: Siis võib ravimsööda granuleerida.
English: No breakpoint for Brachyspira hyodysenteriae has been established.
Estonian: Brachyspira hyodysenteriae suhtes ei ole resistentsust kinnitatud.